SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-15-000749
Filing Date
2015-04-30
Accepted
2015-04-30 16:32:11
Documents
13
Period of Report
2015-06-02
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A b408251_def14a.htm DEF 14A 1279851
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_sareptaside-pms.jpg GRAPHIC 36148
4 GRAPHIC sig_davidt-howton.jpg GRAPHIC 15320
5 GRAPHIC sig_edeward-kaye.jpg GRAPHIC 24215
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v407642_chrt-bar1.jpg GRAPHIC 53562
8 GRAPHIC v407642_chrt-bar2.jpg GRAPHIC 54252
9 GRAPHIC v407642_chrt-bar3.jpg GRAPHIC 84058
10 GRAPHIC v407642_chrt-bar4.jpg GRAPHIC 86067
11 GRAPHIC v407642_chrt-pie.jpg GRAPHIC 45244
12 GRAPHIC v407642_pc1.jpg GRAPHIC 521741
13 GRAPHIC v407642_pc2.jpg GRAPHIC 372611
  Complete submission text file 0001174947-15-000749.txt   3064903
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 15819230
SIC: 2834 Pharmaceutical Preparations